litlas
ログインアカウント作成

Derek T. O’Hagan

1989–2024 年に発表

別表記
Derek T. O'Hagan
120
論文数
20,498
被引用数
87
h 指数
120
i10 指数

被引用数

Derek T. O’Hagan の年別被引用数1974 年: 被引用 1 件1990 年: 被引用 3 件1991 年: 被引用 5 件1992 年: 被引用 6 件1993 年: 被引用 30 件1994 年: 被引用 31 件1995 年: 被引用 35 件1996 年: 被引用 61 件1997 年: 被引用 62 件1998 年: 被引用 123 件1999 年: 被引用 63 件2000 年: 被引用 60 件2001 年: 被引用 110 件2002 年: 被引用 85 件2003 年: 被引用 155 件2004 年: 被引用 183 件2005 年: 被引用 126 件2006 年: 被引用 153 件2007 年: 被引用 137 件2008 年: 被引用 152 件2009 年: 被引用 191 件2010 年: 被引用 170 件2011 年: 被引用 210 件2012 年: 被引用 192 件2013 年: 被引用 172 件2014 年: 被引用 184 件2015 年: 被引用 191 件2016 年: 被引用 152 件2017 年: 被引用 151 件2018 年: 被引用 172 件2019 年: 被引用 430 件2020 年: 被引用 530 件2021 年: 被引用 782 件2022 年: 被引用 684 件2023 年: 被引用 587 件2024 年: 被引用 844 件2025 年: 被引用 374 件2026 年: 被引用 5 件1975〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,827 件、この内訳の 27.7%中国: 引用元論文 801 件、この内訳の 12.2%イギリス: 引用元論文 415 件、この内訳の 6.3%インド: 引用元論文 249 件、この内訳の 3.8%ドイツ: 引用元論文 244 件、この内訳の 3.7%イタリア: 引用元論文 233 件、この内訳の 3.5%カナダ: 引用元論文 205 件、この内訳の 3.1%スイス: 引用元論文 200 件、この内訳の 3%オーストラリア: 引用元論文 188 件、この内訳の 2.9%フランス: 引用元論文 188 件、この内訳の 2.9%韓国: 引用元論文 169 件、この内訳の 2.6%オランダ: 引用元論文 161 件、この内訳の 2.4%
0%27.7%その他 25.9%

機関

分野

  • Immunology and Microbiology31.9%
  • Medicine26%
  • Biochemistry, Genetics and Molecular Biology24.1%
  • Pharmacology, Toxicology and Pharmaceutics9.1%
  • Agricultural and Biological Sciences2.6%
  • Materials Science2.3%
  • その他4%

トピック

  • Immunotherapy and Immune Responses12.5%
  • RNA Interference and Gene Delivery9.4%
  • SARS-CoV-2 and COVID-19 Research4.9%
  • Advanced Drug Delivery Systems4.2%
  • Immune Response and Inflammation4%
  • Immune Cell Function and Interaction2.9%
  • その他62.1%

共著者

全論文

検索で開く
  1. Emerging concepts in the science of vaccine adjuvants

    著者: Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan - Nature Reviews Drug Discovery 2021 被引用: 1,356

  2. Nonviral delivery of self-amplifying RNA vaccines

    著者: Andrew J. Geall, Ayush Verma, Gillis R. Otten, Christine A. Shaw, Armin Hekele, Kaustuv Banerjee, Yen Cu, Clayton W. Beard, Luis A. Brito, Thomas Krucker, Derek T. O’Hagan, Manmohan Singh, Peter W. Mason, Nicholas M. Valiante, Philip R. Dormitzer, Susan W. Barnett, Rino Rappuoli, Jeffrey B. Ulmer, Christian W. Mandl - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 667

  3. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

    著者: Prabhu S. Arunachalam, Alexandra C. Walls, Nadia Golden, Caroline Atyeo, Stephanie Fischinger, Chunfeng Li, Pyone P. Aye, Mary Jane Navarro, Lilin Lai, Venkata Viswanadh Edara, Katharina Röltgen, Kenneth A. Rogers, Lisa Shirreff, Douglas E. Ferrell, Samuel Wrenn, Deleah Pettie, John C. Kraft, Marcos C. Miranda, Elizabeth Kepl, Claire Sydeman, Natalie Brunette, Michael Murphy, Brooke Fiala, Lauren Carter, Alexander G. White, Meera Trisal, Ching‐Lin Hsieh, Kasi Russell‐Lodrigue, Christopher Monjure, Jason Dufour, Skye Spencer, Lara Doyle‐Meyers, Rudolph P. Bohm, Nicholas J. Maness, Chad J. Roy, Jessica A. Plante, Kenneth S. Plante, Alex Zhu, Matthew J. Gorman, Sally Shin, Xiaoying Shen, Jane Fontenot, Shakti Gupta, Derek T. O’Hagan, Robbert van der Most, Rino Rappuoli, Robert L. Coffman, David Novack, Jason S. McLellan, Shankar Subramaniam, David C. Montefiori, Scott D. Boyd, JoAnne L. Flynn, Galit Alter, François Villinger, Harry Kleanthous, Jay Rappaport, Mehul S. Suthar, Neil P. King, David Veesler, Bali Pulendran - Nature 2021 被引用: 353

  4. A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

    著者: Luis A. Brito, Michelle Y. Chan, Christine A. Shaw, Armin Hekele, Thomas Carsillo, Mary Schaefer, Jacob Archer, Anja Seubert, Gillis R. Otten, Clayton W. Beard, Antu Dey, Anders Lilja, Nicholas M. Valiante, Peter W. Mason, Christian W. Mandl, Susan W. Barnett, Philip R. Dormitzer, Jeffrey B. Ulmer, Manmohan Singh, Derek T. O’Hagan, Andrew J. Geall - Molecular Therapy 2014 被引用: 333

  5. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines

    著者: Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo - Molecular Pharmaceutics 2021 被引用: 145

  6. Mechanism of action of mRNA-based vaccines

    著者: Carlo Iavarone, Derek T. O’Hagan, Dong Yü, Nicolas F. Delahaye, Jeffrey B. Ulmer - Expert Review of Vaccines 2017 被引用: 247

  7. Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want

    著者: Harm HogenEsch, Derek T. O’Hagan, Christopher B. Fox - npj Vaccines 2018 被引用: 392

  8. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

    著者: Alexandra C. Walls, Marcos C. Miranda, Alexandra Schäfer, Minh N. Pham, Allison J. Greaney, Prabhu S. Arunachalam, Mary-Jane Navarro, M. Alejandra Tortorici, Kenneth A. Rogers, Megan A. O’Connor, Lisa Shirreff, Douglas E. Ferrell, John E. Bowen, Natalie Brunette, Elizabeth Kepl, Samantha K. Zepeda, Tyler N. Starr, Ching‐Lin Hsieh, Brooke Fiala, Samuel Wrenn, Deleah Pettie, Claire Sydeman, Kaitlin R. Sprouse, Max Johnson, Alyssa Blackstone, Rashmi Ravichandran, Cassandra Ogohara, Lauren Carter, Sasha W. Tilles, Rino Rappuoli, Sarah R. Leist, David R. Martinez, Matthew Clark, Roland Tisch, Derek T. O’Hagan, Robbert van der Most, Wesley C. Van Voorhis, Davide Corti, Jason S. McLellan, Harry Kleanthous, Timothy P. Sheahan, Kelly D. Smith, Deborah H. Fuller, François Villinger, Jesse D. Bloom, Bali Pulendran, Ralph S. Baric, Neil P. King, David Veesler - Cell 2021 被引用: 192

  9. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency

    著者: Giulia Anderluzzi, Gustavo Lou, Stuart Woods, S. Schmidt, Simona Gallorini, Michela Brazzoli, Russell Johnson, Craig W. Roberts, Derek T. O’Hagan, Barbara C. Baudner, Yvonne Perrie - Journal of Controlled Release 2021 被引用: 96

  10. The mechanism of action of MF59 – An innately attractive adjuvant formulation

    著者: Derek T. O’Hagan, Gary Ott, Ennio De Gregorio, Anja Seubert - Vaccine 2012 被引用: 475

  11. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection

    著者: Gustavo Lou, Giulia Anderluzzi, S. Schmidt, Stuart Woods, Simona Gallorini, Michela Brazzoli, Fabiola Giusti, Ilaria Ferlenghi, Russell N. Johnson, Craig W. Roberts, Derek T. O’Hagan, Barbara C. Baudner, Yvonne Perrie - Journal of Controlled Release 2020 被引用: 164

  12. Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines

    著者: Roshan Goswami, Despo Chatzikleanthous, Gustavo Lou, Fabiola Giusti, Alessandra Bonci, Marianna Taccone, Michela Brazzoli, Simona Gallorini, Ilaria Ferlenghi, Francesco Berti, Derek T. O’Hagan, Carlo Pergola, Barbara C. Baudner, Roberto Adamo - ACS Infectious Diseases 2019 被引用: 112

  13. “World in motion” – emulsion adjuvants rising to meet the pandemic challenges

    著者: Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, Margherita Coccia, Giuseppe Lofano - npj Vaccines 2021 被引用: 111

  14. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake

    著者: Frank Liang, Gustaf Lindgren, Kerrie J. Sandgren, Elizabeth A. Thompson, Joseph R. Francica, Anja Seubert, Ennio De Gregorio, Susan W. Barnett, Derek T. O’Hagan, Nancy J. Sullivan, Richard A. Koup, Robert A. Seder, Karin Loré - Science Translational Medicine 2017 被引用: 209

  15. The history of MF59 ® adjuvant: a phoenix that arose from the ashes

    著者: Derek T. O’Hagan, Gary Ott, Gary Van Nest, Rino Rappuoli, Giuseppe Del Giudice - Expert Review of Vaccines 2012 被引用: 311

  16. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine

    著者: Yupeng Feng, Meng Yuan, John M. Powers, Mengyun Hu, Jennifer E. Munt, Prabhu S. Arunachalam, Sarah R. Leist, Lorenza Bellusci, JungHyun Kim, Kaitlin R. Sprouse, Lily E. Adams, Sumana Sundaramurthy, Xueyong Zhu, Lisa Shirreff, Michael L. Mallory, Trevor Scobey, Alberto Moreno, Derek T. O’Hagan, Harry Kleanthous, François Villinger, David Veesler, Neil P. King, Mehul S. Suthar, Surender Khurana, Ralph S. Baric, Ian A. Wilson, Bali Pulendran - Science Translational Medicine 2023 被引用: 62

  17. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

    著者: Fiona A. Sharp, Darren Ruane, Benjamin Claass, Emma M. Creagh, James Harris, Padma Malyala, Manomohan Singh, Derek T. O’Hagan, Virginie Pétrilli, Jürg Tschopp, Luke O'neill, Ed C. Lavelle - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 被引用: 536

  18. The continued advance of vaccine adjuvants – ‘we can work it out’

    著者: Derek T. O’Hagan, Rushit N. Lodaya, Giuseppe Lofano - Seminars in Immunology 2020 被引用: 107

  19. Rational design of small molecules as vaccine adjuvants

    著者: Tom Wu, Manmohan Singh, Andrew T. Miller, Ennio De Gregorio, Francesco Doro, Ugo D’Oro, David Skibinski, M. Lamine Mbow, Simone Bufali, Ann Herman, Alex Cortez, Yongkai Li, Bishnu P. Nayak, Elaine Tritto, Christophe Filippi, Gillis R. Otten, Luis A. Brito, Elisabetta Monaci, Chun Li, Susanna Aprea, Sara Valentini, Samuele Calabrό, Donatello Laera, Brunella Brunelli, Elena Caproni, Padma Malyala, Rekha G. Panchal, Travis K. Warren, Sina Bavari, Derek T. O’Hagan, M. Cooke, Nicholas M. Valiante - Science Translational Medicine 2014 被引用: 176

  20. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect

    著者: Samuele Calabrό, Elaine Tritto, Annamaria Pezzotti, Marianna Taccone, Alessandro Muzzi, Sylvie Bertholet, Ennio De Gregorio, Derek T. O’Hagan, Barbara C. Baudner, Anja Seubert - Vaccine 2013 被引用: 215

  21. Molecular and cellular signatures of human vaccine adjuvants

    著者: Flaviana Mosca, Elaine Tritto, Alessandro Muzzi, Elisabetta Monaci, Fábio Bagnoli, Carlo Iavarone, Derek T. O’Hagan, Rino Rappuoli, Ennio De Gregorio - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 被引用: 493

  22. Recent advances in the discovery and delivery of vaccine adjuvants

    著者: Derek T. O’Hagan, Nicholas M. Valiante - Nature Reviews Drug Discovery 2003 被引用: 432

  23. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes

    著者: Samuele Calabrό, Marco Tortoli, Barbara C. Baudner, Alessandra Pacitto, Mario Cortese, Derek T. O’Hagan, Ennio De Gregorio, Anja Seubert, Andreas Wack - Vaccine 2011 被引用: 427

  24. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus

    著者: Fábio Bagnoli, Maria Rita Fontana, Elisabetta Soldaini, Ravi P.N. Mishra, Luigi Fiaschi, Elena Cartocci, Vincenzo Nardi‐Dei, Paolo Ruggiero, Sarah Nosari, Maria Grazia De Falco, Giuseppe Lofano, Sara Marchi, Bruno Galletti, Paolo Mariotti, Marta Bacconi, Antonina Torre, Silvia Maccari, Maria Scarselli, C. Daniela Rinaudo, Naoko Inoshima, Silvana Savino, Elena Mori, Silvia Rossi-Paccani, Barbara C. Baudner, Michele Pallaoro, Erwin Swennen, Roberto Petracca, Cecilia Brettoni, Sabrina Liberatori, Nathalie Norais, Elisabetta Monaci, Juliane Bubeck Wardenburg, Olaf Schneewind, Derek T. O’Hagan, Nicholas M. Valiante, Giuliano Bensi, Sylvie Bertholet, Ennio De Gregorio, Rino Rappuoli, Guido Grandi - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 被引用: 174